Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways. The three most common forms of NSCLC are adenocarcinoma, squamous cell carcinoma and large cell carcino...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
[4]Awad M M,et al.Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer[J]. Cancer Cell, 2022, 40(9): 1010-1026. e11. https://www.cell.com/cancer-cell/fulltext/S1535-6108(22)00359-2?_return...
近期,上海市肺科医院张鹏、张乐乐团队联合同济大学生科院王晨飞团队,同济大学医学院孙毅团队与中科院生化细胞所曾安团队,在Nature Genetics杂志发表题为Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small cell lung cancer的研究论文: ...
近日,一篇发表在国际杂志Nature上题为“Intrinsic electrical activity drives small-cell lung cancer progression”的研究报告中,来自弗朗西斯克里克研究所等机构的科学家们通过研究发现,一些特别具有侵袭性的肺癌细胞能形成自身的电子网络,就好像在人体神经系统中观察到的那样;这种独特的特性就能使其对肿瘤周围环境的依赖性...
这篇题为“Intrinsic electrical activity drives small-cell lung cancer progression”的论文于2025年2月12日发表在《Nature》杂志上。 小细胞肺癌(SCLC)是侵袭性最强的癌症之一,三分之二的患者在初诊时已出现远端转移。这种癌症主要源于神经内分泌(NE)细胞,...
这篇题为“Intrinsic electrical activity drives small-cell lung cancer progression”的论文于2025年2月12日发表在《Nature》杂志上。 小细胞肺癌(SCLC)是侵袭性最强的癌症之一,三分之二的患者在初诊时已出现远端转移。这种癌症主要源于神经内分泌(NE)细胞,它们帮助调节肺部的空气和血液流动。
这篇题为“Intrinsic electrical activity drives small-cell lung cancer progression”的论文于2025年2月12日发表在《Nature》杂志上。 小细胞肺癌(SCLC)是侵袭性最强的癌症之一,三分之二的患者在初诊时已出现远端转移。这种癌症主要源于神经内分泌(NE)细胞,它们帮助调节肺部的空气和血液流动。
从影响因子和分布来看,10分以上高分文章1431篇,CNS大子刊如《Cancer Cell》、《Cell Metabolism》、《Nature Nanotechnology》、《Science Immunology》等总计56篇,联川生物的客户大佬们,强!!! 重磅顶刊《New Engl J Med》两篇!《Nature》两篇!《Cell》三篇!